Correlation Between Anheuser Busch and Opus Genetics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anheuser Busch and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anheuser Busch and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anheuser Busch Inbev and Opus Genetics,, you can compare the effects of market volatilities on Anheuser Busch and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anheuser Busch with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anheuser Busch and Opus Genetics,.

Diversification Opportunities for Anheuser Busch and Opus Genetics,

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Anheuser and Opus is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Anheuser Busch Inbev and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Anheuser Busch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anheuser Busch Inbev are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Anheuser Busch i.e., Anheuser Busch and Opus Genetics, go up and down completely randomly.

Pair Corralation between Anheuser Busch and Opus Genetics,

Considering the 90-day investment horizon Anheuser Busch Inbev is expected to generate 0.28 times more return on investment than Opus Genetics,. However, Anheuser Busch Inbev is 3.59 times less risky than Opus Genetics,. It trades about -0.02 of its potential returns per unit of risk. Opus Genetics, is currently generating about -0.02 per unit of risk. If you would invest  5,713  in Anheuser Busch Inbev on October 21, 2024 and sell it today you would lose (913.00) from holding Anheuser Busch Inbev or give up 15.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Anheuser Busch Inbev  vs.  Opus Genetics,

 Performance 
       Timeline  
Anheuser Busch Inbev 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anheuser Busch Inbev has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Anheuser Busch and Opus Genetics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anheuser Busch and Opus Genetics,

The main advantage of trading using opposite Anheuser Busch and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anheuser Busch position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.
The idea behind Anheuser Busch Inbev and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing